Secor Capital Advisors’s DexCom DXCM Stock Holding History

Secor Capital Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-56,024	Closed	-$2M	–	493
2018 Q3	$2M	Buy	+56,024	New	+$1.74M	0.22%	142

Other funds holding DXCM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Secor Capital Advisors's DXCM Position: Q4 2018 in Review

Secor Capital Advisors sold out of DexCom (DXCM) in Q4 2018, closing a stake of 56,024 shares — an estimated $2M sold.

Secor Capital Advisors first reported a position in DXCM in Q3 2018 and held it in 1 quarter. The position peaked at $2M in Q3 2018. 414 funds tracked by Wall St. Rank hold DXCM as of Q4 2018.

Secor Capital Advisors reported no remaining DexCom position as of Q4 2018 after selling out during the quarter.
Secor Capital Advisors sold 56,024 DexCom shares in Q4 2018, an estimated $2M.
Secor Capital Advisors first reported a position in DexCom in Q3 2018 and held it in 1 quarter.
Secor Capital Advisors's DexCom position peaked at $2M in Q3 2018.
414 funds tracked by Wall St. Rank held DexCom as of Q4 2018.

Based on Secor Capital Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.